Pharmascience Inc.: Clinical Trials

2 trials sponsored by Pharmascience Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated, 1 withdrawn. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 1, Withdrawn 1

Follow Pharmascience Inc.: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19
Isoquercetin (IQC-950AN) - COVID-19
Phase 2WithdrawnInstitut de Recherches Cliniques de Montreal2022-01-012025-03-24
Efficacy, Safety and Tolerability of Enteric-Coated Cholestyramine Capsules for Adult Short Bowel Syndrome
Enteric-Coated Cholestyramine (ECC) Capsule, Placebo - Short Bowel Syndrome
Phase 2TerminatedPharmascience Inc.132019-10-152022-07-19

Conditions studied

COVID-19 (1)  ·  Short Bowel Syndrome (1)

Interventions

Capsules (1)  ·  isoquercitrin (1)

Countries

Poland (1)

Top investigators

Kinga Szczepanek, MD (1)  ·  Konrad Matysiak, MD, PhD (1)  ·  Marek Kunecki, MD, PhD (1)

NIH funding

2018 (1)